Comparative Study of Amla and Adrak as Hypoglycemic and Hypolipidemic Agents in Diabetes Mellitus Type II

Diabetes mellitus type II (T2DM) is a chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency, leading to hyperglycemia and disturbances in lipid metabolism. With the growing burden of diabetes globally, there is an increasing interest in alternative and complementary treatments. This paper examines the hypoglycemic and hypolipidemic effects of Amla (Phyllanthus emblica) and Adrak (Zingiber officinale), two well-known medicinal plants in traditional medicine. By comparing their biochemical effects, mechanisms of action, and potential roles in T2DM management, this study aims to highlight their significance in dietary and therapeutic interventions.